The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 6 , Pages 1220-1227 , June 2008

Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model

Received 22 June 2007 ,Revised 14 September 2007 ,Accepted 4 October 2007.

References 

  1. DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12–30
  2. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831
  3. Maley CC. Multistage carcinogenesis in Barrett's esophagus. Cancer Lett. 2007;245:22–32
  4. Lee JS, Oh TY, Ahn BO, Cho H, Kim WB, Kim YB, et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res. 2001;480-481:189–200
  5. Takubo K, Honma N, Aryal G, Sawabe M, Arai T, Tanaka Y, et al. Is there a set of histologic changes that are invariably reflux associated?. Arch Pathol Lab Med. 2005;129:159–163
  6. Altorki N. COX-2: a target for prevention and treatment of esophageal cancer. J Surg Res. 2004;117:114–120
  7. O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol. 2005;100:1257–1264
  8. Eksteen JA, Scott PA, Perry I, Jankowski JA. Inflammation promotes Barrett's metaplasia and cancer: a unique role for TNFalpha. Eur J Cancer Prev. 2001;10:163–166
  9. Diaz BL, Arm JP. Phospholipase A(2). Prostaglandins Leukot Essent Fatty Acids. 2003;69:87–97
  10. Haapamaki MM, Gronroos JM, Nurmi H, Irjala K, Alanen KA, Nevalainen TJ. Phospholipase A2 in serum and colonic mucosa in ulcerative colitis. Scand J Clin Lab Invest. 1999;59:279–287
  11. Lagorce-Pages C, Paraf F, Wendum D, Martin A, Flejou JF. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus. Virchows Arch. 2004;444:426–435
  12. Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, et al. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem. 1995;270:22378–22385
  13. Wang TC, Goldenring JR, Dangler C, Ito S, Mueller A, Jeon WK, et al. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology. 1998;114:675–689
  14. Stull LB, Hiranandani N, Kelley MA, Leppo MK, Marban E, Janssen PM. Murine strain differences in contractile function are temperature- and frequency-dependent. Pflugers Arch. 2006;452:140–145
  15. Markova M, Koratkar RA, Silverman KA, Sollars VE, MacPhee-Pellini M, Walters R, et al. Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis. Oncogene. 2005;24:6450–6458
  16. Chen X, Yang G, Ding WY, Bondoc F, Curtis SK, Yang CS. An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis. 1999;20:1801–1808
  17. Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2007;5:4–16
  18. Touqui L, Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med. 2001;1:739–754
  19. Grass DS, Felkner RH, Chiang MY, Wallace RE, Nevalainen TJ, Bennett CF, et al. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest. 1996;97:2233–2241
  20. Handler JA, Danilowicz RM, Eling TE. Mitogenic signaling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in BALB/c 3T3 cells. J Biol Chem. 1990;265:3669–3673
  21. Sellmayer A, Uedelhoven WM, Weber PC, Bonventre JV. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J Biol Chem. 1991;266:3800–3807
  22. Katayama M, Shoji M, Satomi S. Differential growth properties of normal and malignant esophageal epithelial cells: a possible cross talk between transforming growth factor-beta1 and epidermal growth factor signaling. Tohoku J Exp Med. 2005;206:61–71
  23. Park DW, Kim JR, Kim SY, Sonn JK, Bang OS, Kang SS, et al. Akt as a mediator of secretory phospholipase A2 receptor-involved inducible nitric oxide synthase expression. J Immunol. 2003;170:2093–2099
  24. Mulherkar R, Rao R, Rao L, Patki V, Chauhan VS, Deo MG. Enhancing factor protein from mouse small intestines belongs to the phospholipase A2 family. FEBS Lett. 1993;317:263–266
  25. Wilkinson NW, Black JD, Roukhadze E, Driscoll D, Smiley S, Hoshi H, et al. Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma. J Gastrointest Surg. 2004;8:448–453
  26. Eerola LI, Surrel F, Nevalainen TJ, Gelb MH, Lambeau G, Laine VJ. Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. Biochim Biophys Acta. 2006;1761:745–756
  27. Ireland AP, Peters JH, Smyrk TC, DeMeester TR, Clark GWB, Mirvish SS, et al. Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg. 1996;223:358–362

 Read at the Thirty-third Annual Meeting of the Western Thoracic Surgical Association, Santa Ana Pueblo, NM, June 27–30, 2007.

 Supported by the University of Colorado Academic Enrichment Funds and the University of Colorado Department of Surgery.

PII: S0022-5223(08)00214-6

doi: 10.1016/j.jtcvs.2007.10.080

The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 6 , Pages 1220-1227 , June 2008

Article Tools

* Image Usage & Resolution